Dutams
Dutams – is a combination of two drugs dutasteride and tamsulosin, which have a complementary effect. Drugs for the treatment of benign prostatic hypertrophy.
active substance – dutasteride 0.5 mg,
excipients: propylene glycol monocaprylate, type II butylhydroxytoluene (E 321),
composition of the gel mass (soft capsule): gelatin (gelling grade, type B, 150), glycerin, titanium dioxide (E171).
– treatment of patients who have previously received both tamsulosin and dutasteride, at the same dosages, in order to adequately control moderate and severe symptoms of benign prostatic hyperplasia (BPH).
To reduce the risk of developing acute urinary retention and surgery in patients with moderate to severe symptoms of prostate adenoma.
Adult men (including the elderly)
1 capsule (0.5 mg / 0.4 mg) orally, once a day, 30 minutes after the same meal, with water. Capsules should be taken whole, without opening or chewing, as contact of the contents of the capsule with the oral mucosa may cause irritation of the oropharyngeal mucosa.
Patients with impaired renal function: There are no data on the use of the drug Dutams in patients with impaired renal function. There is no need for dose adjustment in this group of patients.
Patients with impaired liver function: There are no data on the use of the drug Dutams in patients with impaired liver function. It should be used with caution in patients with mild to moderate hepatic impairment. Dutams is contraindicated in patients with severe hepatic impairment.
Children: Safety and efficacy have not been established in children under 18 years of age.
Composition
active substance – dutasteride 0.5 mg,
excipients: propylene glycol monocaprylate, type II butylhydroxytoluene (E 321),
composition of the gel mass (soft capsule): gelatin (gelling grade, type B, 150), glycerin, titanium dioxide (E171).
Indications for use
– treatment of patients who have previously received both tamsulosin and dutasteride, at the same dosages, in order to adequately control moderate and severe symptoms of benign prostatic hyperplasia (BPH).
To reduce the risk of developing acute urinary retention and surgery in patients with moderate to severe symptoms of prostate adenoma.
Mode of application
Adult men (including the elderly)
1 capsule (0.5 mg / 0.4 mg) orally, once a day, 30 minutes after the same meal, with water. Capsules should be taken whole, without opening or chewing, as contact of the contents of the capsule with the oral mucosa may cause irritation of the oropharyngeal mucosa.
Patients with impaired renal function: There are no data on the use of the drug Dutams in patients with impaired renal function. There is no need for dose adjustment in this group of patients.
Patients with impaired liver function: There are no data on the use of the drug Dutams in patients with impaired liver function. It should be used with caution in patients with mild to moderate hepatic impairment. Dutams is contraindicated in patients with severe hepatic impairment.
Children: Safety and efficacy have not been established in children under 18 years of age.